GLP-2 (HUMAN) Chemical Properties

storage temp. 

−20°C

form 

solid

Safety Information

Safety Statements 

22-24/25

WGK Germany 

3

MSDS

• Language:English Provider:SigmaAldrich

GLP-2 (HUMAN) Usage And Synthesis

Uses

Glucagon-Like Peptide 2 (GLP-2) -Arg human trifluoroacetate salt has been used for injection in chickens to determine the effects of GLP-2 on the weight and morphology of small intestines.

General Description

Glucagon-like peptide 2 (GLP-2) is a member of the pro-glucagon gene family which is released in small and large intestinal circulation by enteroendocrine L cells. This peptide is composed of 33 amino acids.

Biochem/physiol Actions

Glucagon-like peptide 2 (GLP-2) influences the functionality of gastrointestinal tract by participating in the feedback loop to the brain for the control of food intake. It also controls digestion and absorption, and has tropic effects post chemotherapy injury or surgical resection. This peptide is also responsible for epithelial cell proliferation of the small bowel. Studies in rats show that this peptide enhances the effects of the ileal-brake hormones, GLP-1 and peptide YY. It also negatively regulates gastrointestinal motility and secretion. Thus, it has potential as a therapeutic agent in short-bowel syndrome.

GLP-2 (HUMAN)(99120-49-7)Related Product Information

• Glucagon
• GLP-2 (HUMAN) TRIFLUOROACETATE SALT
• Glucagon-LikePeptide2(Glp2),Human
• GLP-1 (HUMAN, 7-36 AMIDE) (BOVINE, CANINE, RAT, GUINEA PIG)
• GLP-1 (7-37)
• GLP-1, HUMAN
• GLP-2 (HUMAN)
• GLUCAGONLIKE-PEPTIDE-2(GLP),RABBITANTI-HUMAN:ELISA
• [125I]-GLP-2 (HUMAN)
• ANTI-GLP-2 (HUMAN)
• GLP-1 (HUMAN)
• ANTI-GLP-1, HUMAN